Cetera Investment Advisers Sells 11,220 Shares of The Chemours Company $CC

Cetera Investment Advisers lowered its position in The Chemours Company (NYSE:CC) by 43.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,572 shares of the specialty chemicals company’s stock after selling 11,220 shares during the period. Cetera Investment Advisers’ holdings in Chemours were worth $197,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. FNY Investment Advisers LLC bought a new stake in shares of Chemours in the first quarter worth $27,000. UMB Bank n.a. grew its holdings in shares of Chemours by 73.9% in the first quarter. UMB Bank n.a. now owns 2,231 shares of the specialty chemicals company’s stock worth $30,000 after acquiring an additional 948 shares during the period. Farther Finance Advisors LLC grew its holdings in shares of Chemours by 170.7% in the first quarter. Farther Finance Advisors LLC now owns 2,290 shares of the specialty chemicals company’s stock worth $30,000 after acquiring an additional 1,444 shares during the period. Itau Unibanco Holding S.A. grew its holdings in shares of Chemours by 39.3% in the fourth quarter. Itau Unibanco Holding S.A. now owns 3,554 shares of the specialty chemicals company’s stock worth $60,000 after acquiring an additional 1,003 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Chemours in the fourth quarter worth $91,000. Institutional investors own 76.26% of the company’s stock.

Chemours Price Performance

NYSE:CC opened at $15.3430 on Friday. The company has a current ratio of 1.68, a quick ratio of 0.83 and a debt-to-equity ratio of 17.16. The company has a market capitalization of $2.30 billion, a P/E ratio of -5.48 and a beta of 1.61. The Chemours Company has a 12 month low of $9.13 and a 12 month high of $22.38. The business’s 50-day moving average is $12.90 and its 200 day moving average is $12.96.

Chemours (NYSE:CC) last posted its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.12. The company had revenue of $1.62 billion for the quarter, compared to the consensus estimate of $1.57 billion. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.38 earnings per share. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities research analysts forecast that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 15th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 15th. Chemours’s payout ratio is currently -12.50%.

Insider Transactions at Chemours

In other news, insider Damian Gumpel bought 7,822 shares of the firm’s stock in a transaction that occurred on Tuesday, June 3rd. The shares were bought at an average cost of $9.95 per share, for a total transaction of $77,828.90. Following the completion of the transaction, the insider owned 131,701 shares of the company’s stock, valued at approximately $1,310,424.95. This represents a 6.31% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Denise Dignam bought 4,068 shares of the firm’s stock in a transaction that occurred on Friday, August 8th. The stock was purchased at an average price of $12.06 per share, for a total transaction of $49,060.08. Following the completion of the transaction, the chief executive officer directly owned 191,546 shares of the company’s stock, valued at $2,310,044.76. This represents a 2.17% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 25,290 shares of company stock worth $250,437 over the last quarter. 0.47% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Barclays cut their price target on Chemours from $16.00 to $13.00 and set an “equal weight” rating for the company in a report on Wednesday, May 28th. Morgan Stanley cut their price target on Chemours from $22.00 to $15.00 and set an “equal weight” rating for the company in a report on Monday, May 12th. Wall Street Zen lowered Chemours from a “hold” rating to a “sell” rating in a report on Wednesday, May 21st. Royal Bank Of Canada boosted their price target on Chemours from $14.00 to $15.00 and gave the company an “outperform” rating in a report on Thursday, July 3rd. Finally, Mizuho boosted their price objective on Chemours from $13.00 to $16.00 and gave the company an “outperform” rating in a research report on Tuesday, July 15th. Five equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $17.38.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.